Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × XELOX × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 26 Stomach Neoplasms 24 Rectal Neoplasms 22 Colonic Neoplasms 12 Neoplasms 3 Neoplasm Metastasis 3 Adenocarcinoma 3 Gastrointestinal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Rcctal Cancer 1 Peripheral Nervous System Diseases 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Locally Advanced Gastric Cancer 1 Intestinal Neoplasms 1 HER2-positive Locally Advanced Resectable Gastric Cancer 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Diseases 1 Gastric Cancer Stage 1 Digestive System Diseases 1 Colorectal Cancer Metastatic 1 Colonic Diseases 1 Carcinoma 1 Adenocarcinoma of the Lower Rectum 1 Adebrelimab (SHR-1316) 1

Interventions

Bevacizumab 18 Capecitabine 15 Oxaliplatin 10 Cetuximab 10 Irinotecan 9 Fluorouracil 8 Panitumumab 6 Leucovorin 6 aflibercept 5 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Ipilimumab 2 Drug Therapy 2 spartalizumab 1 raltitrexed 1 pembrolizumab 1 masitinib 1 irinotecan sucrosofate 1 folfirinox 1 camrelizumab 1 balstilimab 1 atezolizumab 1 anisodamine 1 XELOX 1 Tyrosine Kinase Inhibitors 1 Tomography, X-Ray Computed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01910610 2024-03-12

STRATEGIC-1

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Active not recruiting

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡